CHRONIC MYELOID LEUKEMIA EPIDEMIOLOGY IN THE FERGANA REGION OVER DECADE: FROM 2010 UNTIL 2020.

M. Palvanova; B. Akhmatov

doi:10.5281/zenodo.7479244

CHRONIC MYELOID LEUKEMIA EPIDEMIOLOGY IN THE FERGANA REGION OVER DECADE: FROM 2010 UNTIL 2020.

24.12.2022 International Scientific Journal "Science and Innovation". Series D. Volume 1 Issue 8

M. Palvanova , B. Akhmatov

Abstract. CML is caused by a genetic change (mutation) in the stem cells produced by the bone marrow.The mutation causes the stem cells to produce too many underdeveloped white blood cells. It also leads to a reduction in the number of other blood cells, such as red blood cells. Examine the epidemiology of Chronic Myeloid Leukemia (CML) in the Fergana region, compare it to other populations, and identify factors that influence the disease's causes.

Keywords: Chronic myeloid leukemia (CML), hematology, epidemiology, Fergana, Ph- chromosome

References:

1. Cancer Facts & Figures is an annual publication of the American Cancer Society, Atlanta, Georgia cancer.org | 1.800.227.2345 80-(16) 2. https://gco.iarc.fr/today/about#references // Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed [DD Month YYYY]. 3. Adithya Chennamadhavuni 1, Varun Lyengar 2, Alex Shimanovsky 2 : Leukemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. 2022 May 4. Affiliations expand PMID: 32809325 Bookshelf ID: NBK560490 4. M. Deininger, N. Shah, +26 authors Hema M Sundar: Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Medicine Journal of the National Comprehensive Cancer Network Volume 18 Issue 10 | October 2020 1386-1415. 5. Arber D, Orazi A. The updated WHO classification of hematological malignancies: the 2016 revision to the WHO classification of myeloid neoplasms and acute leukemia. Blood J. 2016;127:2391–2405. [PubMed] [Google Scholar] 6. Axel Karow 1,2,* , Gudrun Göhring 3 , Stephanie Sembill 1,2, Friederike Lutterloh 3 , Fina Neuhaus 3 , Sara Callies 3 , Elke Schirmer 1,2, Zofia Wotschofsky 1,2, Oisin Roche-Lancaster 2,4, Meinolf Suttorp 5 , Manuela Krumbholz 1,2 and Markus Metzler 1,2 1: The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase Cancers 2022, 14(7), 1712; https://doi.org/10.3390/cancers14071712 7. https://www.analyticssteps.com/blogs/7-types-statistical-analysis-definition-explanation 8. Ahmed Mjali1, Haider Hasan Jaleel Al-Shammari2 Zahraa Deheyaa Azeez4, Saja Khudhair Abbas. Leukemia Epidemiology in Karbala province of Iraq. Asian Pac J Cancer Care, 4 (4), 135-139 Submission Date: 04/08/2019 Acceptance Date: 07/12/2019 9. Hossain MS, Iqbal MS, Khan MA, Rabbani MG, Khatun H, Munira S, Miah MM, Kabir AL, Islam N, Dipta TF, Rahman F. Diagnosed hematological malignancies in Bangladesh-a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC cancer. 2014 Dec; 14(1):438 10. AlameriA,Khudhair M ,BatoolG,Murad N. Epidemiology of chronic myeloid leukemia in Iraqi patients.14th Congress of the European Hematology Association Abstract Book haematologica 2009; 94(s2), p 578. 11. Alwan AF. Assessment of cytogenetic response after treatment with imatinibmesylate in patients with chronic phase chronic myeloid leukemia. Iraqi J Hematology. 2014;3(1): 56-61.